Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up

BACKGROUND: Efficacious immune-based therapy in treated chronic HIV-1 infection requires the induction of virus-specific CD4(+ )T cells and subsequent maturation and maintenance of specific memory CD8(+ )T cells. Concomitant daily administration of recombinant human growth hormone (rhGH) with highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Herasimtschuk, Anna A, Westrop, Samantha J, Moyle, Graeme J, Downey, Jocelyn S, Imami, Nesrina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613878/
https://www.ncbi.nlm.nih.gov/pubmed/18976455
http://dx.doi.org/10.1186/1476-8518-6-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613878/
https://www.ncbi.nlm.nih.gov/pubmed/18976455
http://dx.doi.org/10.1186/1476-8518-6-7

Ejemplares similares